Akylox Therapeutics ApS

Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

CVR 44 97 40 45AnpartsselskabFrederiksbergStiftet 2024

S is a biotechnology company whose principal activities comprise the research and development of pharmaceutical compounds. The Company’s activities are focused on the development of inhibitors targeting PI3K, based on licensed intellectual property.